Non-blocking anti-TNFR2 human antibody (Beijing Biocytogen Co Ltd)

N/A

Report date: 2022/11/18 18:16:24

Base Information

Drug NameNon-blocking anti-TNFR2 human antibody (Beijing Biocytogen Co Ltd)
Drug Alias Name1C31-C-3BCG003BCG-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 1B
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBiocytogen Pharmaceuticals (Beijing) Co LtdDragonboat Biopharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesBiocytogen Pharmaceuticals (Beijing) Co LtdDragonboat Biopharmaceutical
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A